CYFIP2

Cytoplasmic FMR1-interacting protein 2 · Q96F07 · CYFIP2 on Sugi Atlas →

0 patent compounds predicted against CYFIP2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to CYFIP2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Investigator-initiated Clinical Trial of MIKE-1 PHASE1/PHASE2UNKNOWN
An Open-Label Trial of Donepezil in Fragile X Syndrome PHASE1COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
Single-Dose AAV-MECP2 Safety/Tolerability and Efficacy in Rett Syndrome EARLY_PHASE1ACTIVE_NOT_RECRUITING
Probiotic Intervention for Microbiome Modifications and Clinical Improvements in Fragile X Syndrome nanUNKNOWN
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Optical Imaging as a Tool for Monitoring Brain Function in Fragile X Syndrome nanUNKNOWN
Study of the Genetic Factors Involved in Autism and Related Disorders nanRECRUITING
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
Inter-regional Project of the Great Western Exploration Approach for Exome Molecular Causes Severe Intellectual Disability Isolated or Syndromic nanCOMPLETED
Clinical Phenotyping and Characterization of Neural Networks and Cognitive Processes Involved in Mental Retardation X-linked nanUNKNOWN
Immune Cell Response to Stimuli nanRECRUITING
Susceptibility Genes in Autism Spectrum Disorders nanCOMPLETED
Group CBT in Adolescents With Fragile X Syndrome and in Adolescents With Autism Spectrum Disorder nanRECRUITING
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Blood-based Biomarkers for the Prognosis of Sports Related Concussion nanCOMPLETED
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF) nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN) nanRECRUITING
Family Blood Pressure Program - GenNet Network nanCOMPLETED
Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants nanRECRUITING
Protein Synthesis in the Brain of Patients With Fragile X Syndrome nanCOMPLETED
Genetic Analysis of Heart Channelopathies in Brazilian Patients and Their Relatives nanUNKNOWN
Study of the Involvement of 15q11 - q13 Chromosome Region and CYFIP1 Gene in Autism. Attempt a Genotype-phenotype Correlation nanCOMPLETED
Study of the Pathophysiological Mechanisms Involved in Bleeding Events nanCOMPLETED
Various Type of Genetic Events in Patients With Intellectual Disability nanUNKNOWN
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Decisional Capacity and Informed Consent in Fragile X Syndrome nanCOMPLETED
Family Blood Pressure Program - SAPPHIRe Network nanCOMPLETED
Family Blood Pressure Program - HyperGEN nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a CYFIP2 binder may also engage these)

ProteinNameSimilarity
Q5SQX6 1.000 Q5SQX6 →
Q6GQD1 1.000 Q6GQD1 →
CYFIP1 Cytoplasmic FMR1-interacting protein 1 1.000 landscape →
Q7TMB8 1.000 Q7TMB8 →
Q90YM8 1.000 Q90YM8 →
Q299G2 0.999 Q299G2 →
Q5R414 0.998 Q5R414 →
P55162 0.997 P55162 →
Q9VF87 0.997 Q9VF87 →
A7RU46 0.996 A7RU46 →
O44518 0.995 O44518 →
Q640K3 0.992 Q640K3 →
P55163 0.992 P55163 →
Q6UK63 0.991 Q6UK63 →
Q8K1X4 0.991 Q8K1X4 →
Q9VUY8 0.990 Q9VUY8 →
Q5S2C3 0.990 Q5S2C3 →
NCKAP1L Nck-associated protein 1-like 0.989 landscape →
Q54IR8 0.989 Q54IR8 →
Q7Q6D9 0.989 Q7Q6D9 →
Q1E024 0.988 Q1E024 →
A1CXW3 0.988 A1CXW3 →
Q54R74 0.988 Q54R74 →
Q16X15 0.988 Q16X15 →
Q5R6L2 0.988 Q5R6L2 →
Q6FKQ4 0.987 Q6FKQ4 →
Q60PC0 0.987 Q60PC0 →
Q3UHQ6 0.987 Q3UHQ6 →
Q99K74 0.987 Q99K74 →
Q5ZLS8 0.987 Q5ZLS8 →